Skip to main content

Anakinra News

FDA Approves Kineret (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)

WALTHAM, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) – Sobi™, an international biopharmaceutical company dedicated to rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved ...

FDA approves Kineret for the treatment of NOMID

Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

COVID-19, Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis

Anakinra patient information at Drugs.com